Link between high fetuin-A and lower cardio risk modified by T2DM, obesity, insulin resistance….

The smaller pancreas that is often found in patients with type 1 diabetes was also seen in people at risk for the disease, pointing to a possible diabetes biomarker….

In last Saturday’s newsletter, my editorial focused on physical activity and how the new year brings all kinds of exercise programs that will make our patients thinner and healthier in only a matter of minutes a day. We know that these programs rarely work long term and our patients sometimes get …

Richard S. Beaser, MD, Edward S. Horton, MD and Catherine A. Mullooly, MS, RCEP, CDE The weeks excerpt answers the following questions: Explains how to lower risk of diabetes by 58% How many daily minutes of exercise is recommended Importance of free fatty acids What are the two major sources …

  In this week’s Homerun Slides, we present the second of four parts on glycemic control in hospitals, featuring a closer look at the NICE-SUGAR study and how guidelines were affected subsequent to this study….

I have a very good friend who is a Weight Watcher’s program leader and this week we were talking about how each and every new year, millions of people decide to take control of their own lives, and get fit and healthy. She was sharing how the attendance at her …

  Phase+ Line Launched for Diabetic Skin Care  PHASE+ FOOT THERAPY Naterra announced the launch of Phase+, a skin care line designed to address the cosmetic effects for patients with diabetes. The Phase+ line contains anti-microbial ingredients to help prevent skin care problems such as cracked heels and ultra-dry skin …

Indiana University Health iOS/Free My Healthy Habits, an American Heart Association/Listen To Your Heart initiative, supported by Indiana University Health, helps patients easily build healthy habits into their daily routines.

Many frustrated physicians are likely to abandon Medicare this year over its unpredictable funding despite the decision to delay for one year a cut in Medicare payments for doctors, according to medical associations and physicians. "The Medicare program has become unreliable and its instability undermines efforts by physicians to implement …

Novo Nordisk announced that the Japanese Ministry of Health has approved Ryzodeg® (insulin degludec/insulin aspart) for the treatment of diabetes. Ryzodeg is a soluble formulation of Tresiba (insulin degludec), a once-daily new generation basal insulin analogue with an ultra-long duration of action, and NovoRapid® (insulin aspart which in the US …